Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “COVID-19”

Supported Employment COVID-19 Rapid Testing for PWIDCompleted
NCT05984966NAUpdated Apr 20, 2026
Sponsor: University of Oregon
Health Behavior
United States
Prospective, Open-label Study of Seraph 100 in Patients With Prolonged COVID (PC)Withdrawn
NCT06637800NAUpdated Apr 20, 2026
Sponsor: ExThera Medical Corporation
Long COVID
Mexico
Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVIDActive Not Recruiting
NCT06597396Phase 2Updated Apr 20, 2026
Sponsor: Beth Israel Deaconess Medical Center
Post-COVID Condition · Fatigue Symptom
United States
Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy VolunteersCompleted
NCT07450833Phase 1Updated Apr 20, 2026
Sponsor: Benfovir AG
Healthy Volunteers
Bulgaria
A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.Completed
NCT04494984Phase 2, Phase 3Updated Apr 20, 2026
Sponsor: Inmunova S.A.
COVID-19
Argentina
COVID-19 Vaccine Response in Chronic Respiratory ConditionsCompleted
NCT05313087N/AUpdated Apr 20, 2026
Sponsor: National Jewish Health
SARS-CoV Infection
United States
Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in AdultsCompleted
NCT05463068Phase 3Updated Apr 17, 2026
Sponsor: Novavax
COVID-19 · SARS-CoV-2 Infection
United States
Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research ClinicRecruiting
NCT04736732N/AUpdated Apr 17, 2026
Sponsor: Emilia Falcone, MD
Covid19 · Long COVID
Canada
Clinical and Functional Characteristics of Patients Admitted for Severe COVID-19 PneumoniaCompleted
NCT06727474N/AUpdated Apr 17, 2026
Sponsor: Hospital Nacional Profesor Alejandro Posadas
Post-intensive Care Syndrome · COVID-19
Argentina
Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 PandemicCompleted
NCT04367545NAUpdated Apr 17, 2026
Sponsor: University Hospital, Rouen
COVID · RT-ddPCR Multiplex
France
Treatment of Anxiety in Pregnancy StudyCompleted
NCT05064254NAUpdated Apr 17, 2026
Sponsor: Sunnybrook Health Sciences Centre
Anxiety · Pregnancy
Canada
PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19Completed
NCT05954286Phase 2Updated Apr 17, 2026
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
SARS-CoV-2
United States, South Africa, Thailand, Uganda
Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver DiseaseCompleted
NCT05669677N/AUpdated Apr 17, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chronic or Recovered Hepatitis B · Chronic or Recovered Hepatitis C · Chronic or Recovered Hepatitis D · NAFLD
United States
A Clinical Study of MK-4482 in Chinese Healthy Male Participants (MK-4482-009)Completed
NCT06816030Phase 1Updated Apr 16, 2026
Sponsor: Merck Sharp & Dohme LLC
Healthy
China
Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) PneumoniaActive Not Recruiting
NCT04466683Phase 2Updated Apr 16, 2026
Sponsor: Ohio State University
Covid-19 · Sars-CoV2 · Pneumonia
United States, Colombia
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 PandemicRecruiting
NCT04474301N/AUpdated Apr 16, 2026
Sponsor: M.D. Anderson Cancer Center
COVID-19 Infection · Melanoma
United States
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGEActive Not Recruiting
NCT06333704N/AUpdated Apr 16, 2026
Sponsor: ModernaTX, Inc.
SARS-CoV-2
South Korea
Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFSCompleted
NCT06118138N/AUpdated Apr 15, 2026
Sponsor: Charite University, Berlin, Germany
Post-COVID ME/CFS
Germany
Arginine Replacement Therapy in COVID-19Recruiting
NCT05855330Phase 2Updated Apr 15, 2026
Sponsor: Emory University
COVID-19
United States
Feasibility and Benefits of Digital Services During the COVID19 PandemicCompleted
NCT04453475NAUpdated Apr 15, 2026
Sponsor: Jacobs University Bremen gGmbH
Psychosomatic Disorder · Psychological Distress · Psychological Stress · Psychological Disease
Germany
ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19Completed
NCT05238415NAUpdated Apr 15, 2026
Sponsor: Prof. Dr. Sonia Lippke
Long-COVID · Post-COVID · Psychosomatic Disorder · Psychological Distress
Germany
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy RecipientsCompleted
NCT05164016N/AUpdated Apr 15, 2026
Sponsor: St. Jude Children's Research Hospital
Cancer · Hematopoietic System--Cancer · Transplant-Related Cancer · Solid Tumor Malignancy
United States
Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFSRecruiting
NCT07529197N/AUpdated Apr 14, 2026
Sponsor: Charite University, Berlin, Germany
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) · ME/CFS Following COVID-19
Germany
Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTSTerminated
NCT06524739Phase 3Updated Apr 13, 2026
Sponsor: CSL Behring
Post-COVID Postural Orthostatic Tachycardia Syndrome
United States, Canada
Repeat BCG Vaccinations for the Treatment of Established Type 1 DiabetesActive Not Recruiting
NCT02081326Phase 2Updated Apr 13, 2026
Sponsor: Massachusetts General Hospital
Diabetes Mellitus, Type One · Diabetes Mellitus, Type I · Autoimmune Diabetes · Covid19
United States

Previous page Next page